ArticlePloS one2025
Safety assessment of cyclin-dependent kinase 4/6 inhibitors and comparison of time to adverse events.
Siqi Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticlePloS one2025
Siqi Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.